Evaluating the Pharmacokinetics and Safety of Miricorilant

Clinical trial NCT07553663 · RECRUITING

Trial details

NCT number: NCT07553663
Sponsor: Corcept Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-alcoholic Fatty Liver Disease (NAFLD)

Start date: 2026-04-30
Primary completion: 2026-10-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.